Astrid Katzer

Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.

Journal: BMC cancer

Published: November 02, 2020

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule.

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule.

Journal: Oncotarget

Published: August 09, 2018

Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.

Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.

Journal: BMC cancer

Published: May 09, 2018

Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.

Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.

Journal: Oncotarget

Published: January 12, 2017

Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.

Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.

Journal: Oncology reports

Published: September 06, 2016

Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule.

Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule.

Journal: Oncotarget

Published: September 24, 2015

A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome.

A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome.

Journal: BMC cancer

Published: February 09, 2015

Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status.

Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status.

Journal: Experimental cell research

Published: June 23, 2014

Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status.

Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status.

Journal: PloS one

Published: September 12, 2013

Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule.

Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule.

Journal: Translational oncology

Published: October 22, 2012

Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.

Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.

Journal: Bioorganic & medicinal chemistry

Published: September 24, 2012

Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.

Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.

Journal: Radiation oncology (London, England)

Published: September 24, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026